Discovery of minor quality evaluation marker compounds for Chinese patent medicine products using a two-leveled metabolomics strategy

Volume: 1652, Pages: 462354 - 462354
Published: Aug 1, 2021
Abstract
Chinese patent medicines (CPMs) are popularly used in clinical practice. Though the composition is complex, the quality of CPM is usually evaluated by the contents of a few main compounds. In this study, a two-leveled metabolomics strategy was proposed to discover minor marker compounds for different CPM products. Zhenqi Fuzheng (ZQFZ) granule was studied an example, where 15 batches from 3 producers were analyzed. The samples were separated...
Paper Details
Title
Discovery of minor quality evaluation marker compounds for Chinese patent medicine products using a two-leveled metabolomics strategy
Published Date
Aug 1, 2021
Volume
1652
Pages
462354 - 462354
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.